Efficacy of the Proactive Automatized Lifestyle Intervention
ePAL
Investigating the Efficacy of the Proactive Automatized Lifestyle Intervention Among General Hospital Patients
2 other identifiers
interventional
788
1 country
1
Brief Summary
Background: Individual brief behavior change interventions often do not sufficiently address the common co-occurrence of multiple health risk behaviors among people. In addition, many interventions often fail to reach the majority of the target population and particularly those people who need them the most. To address these core challenges of individual prevention research, the "Proactive Automatised Lifestyle intervention (PAL)" was developed, a proactive screening and brief intervention driven by psychological health behavior change theory to motivate participants for behavior change. The trial ePAL aims to investigate the efficacy of the multi-behavior change intervention adressing tobacco smoking, alcohol use, diet and physical activity among general hospital patients over 2 years; and to investigate differential efficacy in different subgroups of patients. Methods: All patients admitted to non-intensive care wards on five medical departments within the University Medicine Hospital Greifswald (internal medicine A \& B, surgery, trauma surgery, ear-nose-throat) and aged 18 to 64 years are systematically approached by study assistants and asked to first participate in a survey and then in the randomizd controlled trial, irrespective of their reason of admission. A total of 788 participants is allocated to two study groups. The intervention group receives individualized feedback on all four health risk behaviors to enhance motivation to change identified health risk behaviors. The feedback is driven by psychological behavior change theory, tailored to the participants' current stages of change and delivered after baseline and at months 1 and 3. The control group receives routine care and minimal assessment only. Follow-ups are conducted at months 6, 12 and 24 after baseline; and more are planned for. Efficacy will be measured concerning self-reported change in health risk behaviors, health and motivation to change measures using latent growth curve modelling. Discussion: The trial will provide information on the efficacy of a population-based and individually tailored brief intervention to systematically provide individualized feedback to each patient for a healthy living. When found to be effective and implemented widely, such interventions may contribute to the prevention of widespread non-communicable diseases.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2026
CompletedFirst Posted
Study publicly available on registry
March 2, 2026
CompletedStudy Start
First participant enrolled
June 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2029
July 2, 2026
June 1, 2026
2.9 years
February 12, 2026
June 30, 2026
Conditions
Outcome Measures
Primary Outcomes (5)
Difference in Multiple Health Risk Behavior Index
Behavioral health risk factors are determined when recommendations (WHO, World Cancer Research Fund, German Center of Addiction Issues) are not met; with the total sum score ranging between 0 and 4 behavioral health risk factors (insufficient physical activity, unhealthy diet, alcohol use, tobacco smoking)
month 0, 1, 3, 6, 12, 24
Difference in physical activity
European Health Interview Survey-Physical Activity Questionnaire, three additional items
months 0, 1, 3, 6, 12, 24
Difference in diet
Self-reported number of servings of vegetable and fruit per day; Self-reported intake of fat (gram, kilojoule, kilocalories), fiber (gram), salt (gram), sugar (gram), processed meat per day measured by a 16 item diet screener on the number of servings of vegetable, fruit, other food rich in fiber, sweets, added sugar, sweetened drinks, cheese, convenience food, salted snacks, eggs, fatty fish, red meat, processed meat, butter/ oil, milk and bread per day/ week
months 0, 1, 3, 6, 12, 24
Difference in alcohol use
Alcohol Use Disorder Identification Test - Consumption; alcohol use in past month
months 0, 1, 3, 6, 12, 24
Difference in tobacco smoking
Self-reported number of cigarettes per day; smoking status
months 0, 1, 3, 6, 12, 24
Secondary Outcomes (16)
Difference in stage of change
months 0, 1, 3, 6, 12, 24
Difference in self-efficacy
months 0, 1, 3, 6, 12, 24
Difference in decisional balance
months 0, 1, 3, 6, 12, 24
Difference in processes of change
months 0, 1, 3, 6, 12, 24
Difference in general health
month 0, 6, 12, 24
- +11 more secondary outcomes
Study Arms (2)
Digital multi-behavior change intervention
EXPERIMENTALProactive Automatized Lifestyle intervention Frequency: 3 times (month 0, 1, 3) Dosage: Individually tailored feedback corresponding to about 1-6 pages Duration: 3 months
Minimal assessment
NO INTERVENTIONRoutine care and minimal assessment only
Interventions
addresses tobacco smoking, alcohol use, unhealthy diet and insufficient physical activity, individually-tailored, theory-driven, repetitive with three intervention contacts, normative and ipsative feedback, online feedback.
Eligibility Criteria
You may qualify if:
- Admitted to participating wards of the University Medicine Hospital Greifswald on Mondays through Thursdays
You may not qualify if:
- cognitively or physically incapable
- presence of a highly infectious disease
- discharged or transferred within the first 24 hours
- already recruited for study during previous stay
- insufficient German language skills
- employed the conducting research department
- accompanying persons
- no email address (and no phone number)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Medicine Greifswaldlead
- Robert Koch Institute Berlincollaborator
- University Hospital Lübeckcollaborator
Study Sites (1)
University Medicine Hospital Greifswald
Greifswald, 17495, Germany
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and enrollment staff are masked before enrollment; the outcome assessors are masked for follow-up assessment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
February 12, 2026
First Posted
March 2, 2026
Study Start
June 25, 2026
Primary Completion (Estimated)
June 1, 2029
Study Completion (Estimated)
June 1, 2029
Last Updated
July 2, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- The data won't be publicly available due to data protection regulations in Germany.
- Access Criteria
- Aggregated data may be made available on reasonable request that complies with the study purpose, the participants' informed consent and the German data protection lay. The request will be reviewed by the principle investigator.
IPD that underlie results in a publication may be shared